Pages that link to "Q34394171"
Jump to navigation
Jump to search
The following pages link to Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors (Q34394171):
Displaying 14 items.
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases (Q26739120) (← links)
- Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy (Q26783032) (← links)
- Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor. (Q33873157) (← links)
- Dual Inhibitors Against Topoisomerases and Histone Deacetylases (Q35821010) (← links)
- Peptides and Peptide Analogs to Inhibit Protein-Protein Interactions (Q36033291) (← links)
- Romidepsin targets multiple survival signaling pathways in malignant T cells (Q36254237) (← links)
- Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression. (Q38212160) (← links)
- Multitarget Drugs: an Epigenetic Epiphany. (Q38739347) (← links)
- Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors (Q38930297) (← links)
- HDACs and HDAC Inhibitors in Cancer Development and Therapy (Q38947405) (← links)
- Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes (Q38982458) (← links)
- Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells (Q42009840) (← links)
- Selenium protects against cadmium-induced kidney apoptosis in chickens by activating the PI3K/AKT/Bcl-2 signaling pathway (Q47833831) (← links)
- Multitarget inhibition of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K): Current and future prospects (Q100529887) (← links)